An Israeli drug company plans to purchase an American producer for $7.5 billion.
Teva Pharmaceuticals announced Friday its intention to purchase New Jersey-based Barr Pharmaceuticals in a purchase that, if completed, would be the largest ever by an Israeli company, Ha’aretz reported.
The $7.5 billion price tag is 44 percent above Barr’s market value. Teva is the largest generic drug maker in the world.
Support the Jewish Telegraphic Agency
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
